The prevention of Bone Cement Implantation Syndrome (BCIS) begins with a thorough preoperative evaluation, which is crucial for identifying high-risk patients undergoing cemented bone surgery, such as total hip replacements. Communication among surgical, anesthetic, and medical teams is vital for selecting the appropriate prosthesis and surgical technique tailored to the individual patient’s risk profile. Notably, it is essential to assess and optimize patients' cardiovascular reserves prior to surgery. Specific patient-related factors significantly correlate with the risk of developing BCIS, including age over 65, male sex, an ASA score of three or above, severe cardiopulmonary disease, pre-existing pulmonary hypertension, and the use of certain medications like diuretics and warfarin. Additional risk factors include poor physical reserves, malignant tumors, osteoporosis, bony metastases, and certain types of fractures, particularly pathological hip and intertrochanteric fractures. Chronic obstructive pulmonary disease (COPD) complicates the risk further by increasing the chances of hypoxia, acidemia, and inflammatory responses.
Surgical Considerations and Techniques
Surgical practices also play a significant role in minimizing the risk of BCIS. Patients with previously un-instrumented femoral canals are at a higher risk for developing BCIS than those undergoing revision surgery. The use of long-stem femoral components increases this risk, underscoring the need for careful selection of surgical instruments and techniques. While there is no definitive evidence that anesthetic techniques significantly influence the severity of BCIS, certain inhalational agents have been shown to have more substantial hemodynamic effects in BCIS cases. Consequently, nitrous oxide should be avoided to prevent exacerbation of potential air embolisms. Implementing regional anesthesia with minimal sedation allows for better monitoring of the patient’s mental status and respiratory distress during procedures.
The preparation and application of bone cement are critical to preventing BCIS. Employing techniques such as the bone-vacuum cementing method can significantly reduce cement porosity, thereby decreasing the risk of embolic particles entering circulation. Furthermore, retrograde insertion of bone cement using a cement gun helps manage intramedullary pressures, contributing to lower risks of BCIS. Overall, while cemented arthroplasty may show higher perioperative mortality rates compared to uncemented approaches, it can lead to better long-term outcomes and survival rates after one year.
| Domain | Factors that raise risk, and how they are managed |
|---|---|
| Demographics | Age over 65, male sex |
| Physiologic reserve | ASA score of three or above, poor physical reserves |
| Cardiopulmonary disease | Severe cardiopulmonary disease, pre-existing pulmonary hypertension, and COPD, which adds risk of hypoxia, acidemia and inflammatory response |
| Medications | Diuretics, warfarin |
| Bone pathology | Malignant tumors, osteoporosis, bony metastases |
| Fracture type | Pathological hip and intertrochanteric fractures |
| Femoral canal | Previously un-instrumented canals carry higher risk than revision surgery; long-stem femoral components increase risk further |
| Cement handling | Cement porosity, reduced by bone-vacuum cementing; intramedullary pressure, managed by retrograde insertion with a cement gun |
| Anesthetic agents | Nitrous oxide should be avoided so that any air embolism is not worsened |
Monitoring During Surgery
Intraoperative vigilance is essential for the early detection of BCIS. Monitoring should include continuous capnography to identify sudden decreases in end-tidal carbon dioxide (ETCO2), a critical indicator of BCIS. Likewise, pulse oximetry is necessary to detect hypoxia, necessitating an increase in inspired oxygen concentration during high-risk phases such as reaming, cementation, and joint reduction. Bradycardia and hypotension are early signs of BCIS that should prompt immediate attention, reinforcing the need for continuous electrocardiography (ECG) and maintaining systolic blood pressure within 20% of the baseline. High-risk patients may benefit from invasive arterial blood pressure monitoring and central venous pressure monitoring to aid in volume optimization. Furthermore, intraoperative cardiac output monitoring through transesophageal Doppler or pulmonary artery flotation catheters can help detect cardiovascular changes and improve fluid management.
